Katharina A. Ponto

The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy

Luigi Bartalena, George J. Kahaly, L. Baldeschi et al. · European Journal of Endocrinology · 2021 · 893 citations · Full text

Translational Medicine, Parathyroid Hormone, Pharmacology +14

A Novel Thyroid Stimulating Immunoglobulin Bioassay Is a Functional Indicator of Activity and Severity of Graves’ Orbitopathy

Simon D. Lytton, Katharina A. Ponto, Michael Kanitz et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 212 citations · Full text

Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial

George J. Kahaly, Michaela Riedl, J. König et al. · The Lancet Diabetes & Endocrinology · 2018 · 212 citations

Methylprednisolone Versus Methylprednisolone, Endocrine Disease, Medicine +5

Myopia and Level of Education

Alireza Mirshahi, Katharina A. Ponto, René Hoehn et al. · Ophthalmology · 2014 · 175 citations

Secondary Education, Educational Psychology, Education +2

Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment

Raymond S. Douglas, George J. Kahaly, Shoaib Ugradar et al. · Ophthalmology · 2021 · 148 citations · Full text